Progress in Cancer Immunotherapy
Seiten
2018
|
Softcover reprint of the original 1st ed. 2016
Springer (Verlag)
978-94-024-1379-3 (ISBN)
Springer (Verlag)
978-94-024-1379-3 (ISBN)
Thisbook provides readers an extensive overview of recent progress in basicand clinical research on cancer immunotherapy. This book covers five major topics, including monoclonalantibodies, biological response modifiers, cancer vaccines, adoptive cellulartherapy and oncolytic viruses.
This
book provides readers an extensive overview of recent progress in basic
and clinical research on cancer immunotherapy. Thanks to rapid advances in
molecular biology and immunology, it has become increasingly evident that
cancer growth is influenced by host immune responses. With the success of a
number of clinical trials, immunotherapy has become a promising treatment
modality of cancer. This book covers five major topics, including monoclonal
antibodies, biological response modifiers, cancer vaccines, adoptive cellular
therapy and oncolytic viruses. It also examines the combination of different
immune strategies as well as the combination of immunotherapy with other
treatments to increase anti-tumor effects. Through
the
comprehensive discussion of the topic, the book sheds valuable new light on the
treatment of tumors.
This
book provides readers an extensive overview of recent progress in basic
and clinical research on cancer immunotherapy. Thanks to rapid advances in
molecular biology and immunology, it has become increasingly evident that
cancer growth is influenced by host immune responses. With the success of a
number of clinical trials, immunotherapy has become a promising treatment
modality of cancer. This book covers five major topics, including monoclonal
antibodies, biological response modifiers, cancer vaccines, adoptive cellular
therapy and oncolytic viruses. It also examines the combination of different
immune strategies as well as the combination of immunotherapy with other
treatments to increase anti-tumor effects. Through
the
comprehensive discussion of the topic, the book sheds valuable new light on the
treatment of tumors.
Dr. Shuren Zhang is a professor and the director of Department of Immunology, Cancer Institute & Hospital，Chinese Academy of Medical Sciences & Peking Union Medical College. He is the vice chairman of the society of Cancer Biotherapy of Chinese Anti-Cancer Association. His research focuses on tumor immunology and cancer immunotherapy, and he has published more than 60 research articles in this field.
Antibody
therapies in cancer.- Biological Response Modifier in Cancer Immunotherapy.- Progress and Development of Therapeutic Cancer Vaccines.- Adoptive Cellular Therapy
(ACT) for Cancer Treatment.- Oncolytic
Immunotherapy for Treatment of Cancer.
| Erscheinungsdatum | 18.08.2018 |
|---|---|
| Reihe/Serie | Advances in Experimental Medicine and Biology ; 909 |
| Zusatzinfo | 14 Illustrations, color; 1 Illustrations, black and white; XII, 283 p. 15 illus., 14 illus. in color. |
| Verlagsort | Dordrecht |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
| Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| Schlagworte | Antibody • Cancer Immunotherapy • Cellular immunotherapy • Oncolytic virus • Vaccine |
| ISBN-10 | 94-024-1379-0 / 9402413790 |
| ISBN-13 | 978-94-024-1379-3 / 9789402413793 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller
Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
CHF 30,75
Die revolutionäre Medizin von morgen (Lifespan)
Buch | Softcover (2020)
DuMont Buchverlag
CHF 22,40
